|
"pan mr"的相關文件
顯示項目 21-30 / 34 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2018-02 |
CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells
|
Luo, CW;Wu, CC;Chang, SJ;Chang, TM;Chen, TY;Chai, CY;Chang, CL;Hou, MF;Pan, MR |
| 國家衛生研究院 |
2017-09 |
G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response
|
Luo, CW;Wang, JY;Hung, WC;Peng, G;Tsai, YL;Chang, TM;Chai, CY;Lin, CH;Pan, MR |
| 國家衛生研究院 |
2017-08-24 |
The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer
|
Hou, MF;Luo, CW;Chang, TM;Hung, WC;Chen, TY;Tsai, YL;Chai, CY;Pan, MR |
| 國家衛生研究院 |
2017-07-17 |
Orchestration of H3K27 methylation: Mechanisms and therapeutic implication
|
Pan, MR;Hsu, MC;Chen, LT;Hung, WC |
| 國家衛生研究院 |
2016-11 |
Role of epigenetic regulator EHMT2 in the regulation of gemcitabine resistance in pancreatic cancer
|
Hung, WC;Pan, MR;Hsu, MC;Chen, LT;Shan, YS |
| 國家衛生研究院 |
2016-09 |
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer
|
Pan, MR;Hsu, MC;Luo, CW;Chen, LT;Shan, YS;Hung, WC |
| 國家衛生研究院 |
2016-09 |
Beta1 integrin as a prognostic and predictive marker in triple-negative breast cancer
|
Yin, HL;Wu, CC;Lin, CH;Chai, CY;Hou, MF;Chang, SJ;Tsai, HP;Hung, WC;Pan, MR;Luo, CW |
| 國家衛生研究院 |
2016-05-06 |
Connecting the dots: From DNA damage and repair to Aging
|
Pan, MR;Li, K;Lin, SY;Hung, WC |
| 國家衛生研究院 |
2015-12-21 |
G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation
|
Pan, MR;Hsu, MC;Chen, LT;Hung, WC |
| 國家衛生研究院 |
2013-02 |
Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated phosphorylation and activation of Sp1 in breast cancer cells
|
Chuang, CW;Pan, MR;Hou, MF;Hung, WC |
顯示項目 21-30 / 34 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
